Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Bellicum Pharmaceuticals (BLCM)
NASDAQ:BLCM
reports
Bellicum Pharmaceuticals (BLCM) Financial Statements
691 Followers
Bellicum Pharmaceuticals Financial Overview
| Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.00M | $ 0.00 | $ 0.00 | $ 500.00K | $ 5.00M |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -7.21M | $ -4.00M | $ -7.56M | $ 2.53M | $ 1.23M |
| EBITDA | $ -7.21M | $ -4.00M | $ -7.56M | $ 2.55M | $ 1.25M |
| Net Income Common Stockholders | $ -7.21M | $ -4.00M | $ -7.56M | $ 2.53M | $ 764.00K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 28.76M | $ 33.17M | $ 39.77M | $ 46.16M | $ 19.27M |
| Total Assets | $ 31.28M | $ 36.60M | $ 43.43M | $ 49.14M | $ 22.37M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -28.76M | $ -33.17M | $ -39.77M | $ -46.16M | $ -19.27M |
| Total Liabilities | $ 23.78M | $ 22.57M | $ 26.00M | $ 24.75M | $ 34.54M |
| Stockholders Equity | $ 7.50M | $ 14.04M | $ 17.43M | $ 24.39M | $ -12.16M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -5.91M | $ -6.60M | $ -6.38M | $ -6.03M | $ -1.00M |
| Operating Cash Flow | $ -5.91M | $ -6.59M | $ -6.38M | $ -6.03M | $ -996.00K |
| Investing Cash Flow | $ 0.00 | $ -7.00K | $ -7.00K | $ 0.00 | $ -7.00K |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 32.91M | $ 0.00 |
Bellicum Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.